Table 3.

Associations between generalised and institutional trust in wave 2 (age 17–18) and depression and anxiety symptoms in wave 3 (age 20–21). Results from binary logistic and linear regression models. n = 2,668

	Depression symptoms (PHQ-2, cutoff ≥ 3), wave 3
	Crudea		Model 1b		Model 2c		Model 3d
	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI
Generalised trust, wave 2	0.49***	0.41, 0.58	0.64***	0.53, 0.77			0.66***	0.54, 0.80
Institutional trust, wave 2	0.60***	0.50, 0.71			0.79*	0.65, 0.96	0.92	0.75, 1.13
	Anxiety symptoms (GAD-2, cutoff ≥ 3), wave 3
	Crudea		Model 1b		Model 2c		Model 3d
	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI
Generalised trust, wave 2	0.57***	0.48, 0.67	0.72***	0.60, 0.87			0.74**	0.61, 0.91
Institutional trust, wave 2	0.66***	0.56, 0.79			0.83*	0.69, 1.00	0.93	0.76, 1.13
	Depression and anxiety symptoms (PHQ-4, scale 0–12), wave 3
	Crudea		Model 1b		Model 2c		Model 3d
	b	95% CI	b	95% CI	b	95% CI	b	95% CI
Generalised trust, wave 2	-1.19***	-1.40, -0.97	-0.73***	-0.94, -0.51			-0.71***	-0.95, -0.48
Institutional trust, wave 2	-0.77***	-1.00, -0.53			-0.30*	-0.54, -0.06	-0.04	-0.30, 0.22

*** p < 0.001 **p < 0.01 *p < 0.05

^a Includes one variable at a time, controlling for gender

^b Includes generalised trust (measured in wave 2); gender, parental education, parental country of birth (measured in wave 1); and upper secondary programme, medication for depression and anxiety, and psychosomatic complaints (measured in wave 2)

^c Includes institutional trust (measured in wave 2); gender, parental education, parental country of birth (measured in wave 1); and upper secondary programme, medication for depression and anxiety, and psychosomatic complaints (measured in wave 2)

^d Includes generalised and institutional trust (measured in wave 2); gender, parental education, parental country of birth (measured in wave 1); and upper secondary programme, medication for depression and anxiety, and psychosomatic complaints (measured in wave 2)